Industry Symposia
Morning Symposia: Breakfast will be served to session participants from 07:00-07:30, half an hour prior to the start of the session.
Lunch Symposia: Lunch from the congress may be taken into the hall.
Admission to all industry symposia is included as part of the congress registration.
Friday, October 9, 2026
| 07:30-08:30 Hall B (Great Hall 2) |
Morning Industry Symposium New data in breast cancer genomic testing to advance personalized treatment decisions Supported by Veracyte |
 |
| 07:30-08:30 Hall C (Room M1) |
Morning Industry Symposium: Supported by TBA |
|
| 08:30-09:30 Hall C (Room M1) |
Industry Symposium: In conversation with Prof. Javier Cortes: Navigating the complexities of HR+ HER2- early breast cancer Supported by Lilly |
 |
| 11:30-12:30 Hall B (Great Hall 2) |
Industry Symposium: Evolving treatment paradigm in HER2+ early breast cancer Supported by Daiichi-Sankyo | AstraZeneca |
 |
Saturday, October 10, 2026
| 07:30-08:30 Hall B (Great Hall 2) |
Morning Industry Symposium: Recurrence risk and adjuvant treatment decision-making in HR+/HER2− early breast cancer Supported by Novartis |
 |
| 07:30-08:30 Hall C (Room M1) |
Morning Industry Symposium: Optimizing local therapy in early breast cancer: The role of genomic biomarkers DCISionRT and AidaBreast Supported by PreludeDx |
 |
| 13:10-13:55 Hall B (Great Hall 2) |
Industry Lunch Symposium: Redefining the surgical pathway: Contemporary innovations in breast cancer management Supported by Hologic |
 |